Autopsy report · NCT01048567

Efficacy and Safety of Lactobacillus Acidophilus/Rhamnosus Combination for the Prevention of Antibiotic-associated Diarrhea in the Elderly

“Insufficient resources to meet enrollment target”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 8 months before it started.
• Ran for about 1 month before it stopped.
• 7 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Vancouver Island Health Authority

Sponsor type

University, hospital or other

Conditions

Diarrhea; Clostridium Difficile

Interventions

Lactobacillus acidophilus/rhamnosus; Placebo

Participants

7

Sites

1

Countries

Canada

Trials that died the same way

• Effect of Acid Blockade on Microbiota and Inflammation in Cystic Fibrosis (CF)
  “unable to meet the target enrollment goal” (75% match in meaning)
• Randomized Trial Comparing N of 1 Trials to Standard Practice to Improve Adherence to Statins in Patients With Diabetes
  “insufficient recruitment/enrollment” (73% match in meaning)
• Imuran Dosing in Crohn's Disease Study
  “Insufficient enrollment” (72% match in meaning)
• Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder (PTSD)
  “difficulty in achieving target enrollment numbers” (72% match in meaning)
• Vitamine D Treatment in Chronic Heart Failure
  “financial reasons / insufficient enrollment activity” (72% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.